9]/l were not measurable by this automated method and were defined as eosinopenia in this study.
The associations between unplanned ICU re-admission during the same hospitalisation or mortality after ICU discharge and eosinopenia were tested with univariate analyses followed by multivariate analysis.
Because CRP concentrations within 24 hours of ICU discharge were available only in 755 (52%) patients, CRP was only added to the final multivariate model as a sensitivity analysis to assess whether CRP would change the direction and magnitude of the associations between eosinopenia and adverse outcomes after ICU discharge.
Eosinopenia at ICU discharge was significantly more common among those who were re-admitted to the ICU (18.
Peripheral blood eosinophilia occurs in uncomplicated strongyloidiasis, but eosinopenia is associated with a poor clinical prognosis.
The indicators of poor prognosis in this study were sepsis, prerenal azotemia, eosinopenia, HTLV-1 infection, and chronic alcoholism.
Sepsis, prerenal azotemia, eosinopenia, and HTLV-1 infection with chronic alcoholism are indicators of a poor prognosis.
and degenerating eosinophilic leucocytes in blood.
Recently, there has been a resurgence of interest in using eosinopenia as a biomarker of infection.
We hypothesised that eosinopenia is a reliable marker of bloodstream infection in both hospitalised paediatric and adult patients, and conducted a case-control study to assess its diagnostic accuracy as a marker of bloodstream infection, and whether eosinopenia could give additional diagnostic information when combined with the usual conventional markers of infection such as serum CRP concentrations and neutrophil counts.
3]) were not measurable and defined as eosinopenia in this study.
Sensitivity and specificity of eosinopenia and an arbitrarily chosen CRP concentration of >100 mg.
Whether eosinopenia or a combination of eosinopenia and CRP can be used to predict bloodstream infections in critically ill patients remains uncertain.
9]/l) due to bone marrow suppression, either from a primary haematological disease or cytotoxic chemotherapy, were excluded in this study because eosinopenia is expected in these patients.
Among the 22 cases of bloodstream infections included in this study, severe eosinopenia or an undetectable eosinophil count (counts=0) was observed on the day of bloodstream infections in 19 (86%) patients (mean eosinophil counts 0.